Founded in late 2014 by women’s-health researcher David Portman, MD, Columbus-based Sermonix Pharmaceuticals is a privately held biopharmaceutical company developing targeted oncology therapies for women, with a precision-medicine focus. Its lead investigational therapy, oral lasofoxifene, is being studied in the ELAINE clinical programs for ESR1-mutated, hormone receptor-positive/HER2-negative advanced or metastatic breast cancer. Sermonix also conducts patient-centered EQUALS surveys on treatment experiences, sexual health, and quality of life in metastatic breast cancer.
Zetagen TherapeuticsFounded in 2015, Zetagen Therapeutics is a private, clinical-stage biopharmaceutical company built around a patient-centered approach to cancer research. From its Colleen Connor Cancer Research Lab, the company develops local treatments for people with metastatic cancer affecting bone, including the investigational therapy ZetaMet, which is designed to address tumors while supporting bone repair.SYRACUSE, NY
TerSera Therapeutics LLCFounded in 2016, TerSera Therapeutics is a biopharmaceutical company that develops, commercializes, and supports medicines aimed at unmet patient needs. Based in Deerfield, the company combines clinical development expertise with a patient-focused approach and maintains a portfolio spanning oncology, rare disease, and non-opioid pain. Its support programs help patients and providers navigate access and treatment.DEERFIELD, IL
Tactical TherapeuticsFounded in 2005 by cancer scientist and patent attorney Rashida A. Karmali, Tactical Therapeutics is a clinical-stage biopharmaceutical company built around her long career in cancer research, drug development, and intellectual property law. The company develops CTO, an oral therapy designed to reach the brain, for patients with glioblastoma and other cancers that have resisted treatment. Karmali has authored more than 100 scientific publications and holds eight U.S. patents alongside more than 75 international patents.NEW YORK, NY
Duchesnay USADuchesnay USA is a specialty pharmaceutical company developing and providing prescription treatments for women’s health from pregnancy through menopause. Founded as a family-owned company in Québec in 1970, Duchesnay shifted its focus in 1992 to medications safe for use during pregnancy and became the first pharmaceutical company dedicated to safeguarding pregnant women and their unborn babies. Established in the United States in 2011, the company now offers therapeutic options across multiple stages of women’s lives.ROSEMONT, PA